We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+7.67%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$26.7B
AUM Growth
+$3.85B
Cap. Flow
-$4.59B
Cap. Flow %
-17.17%
Top 10 Hldgs %
20.41%
Holding
1,231
New
232
Increased
271
Reduced
149
Closed
114
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSFT icon
1
Microsoft
MSFT
$2.83T
$1.04B 3.87%
3,079,218
+73,162
+2% +$23.7M
AAPL icon
2
Apple
AAPL
$4.72T
$991M 3.71%
5,582,995
+121,172
+2% +$19.1M
AMZN icon
3
Amazon
AMZN
$2.51T
$610M 2.28%
3,661,840
+200,900
+6% +$34.4M
SPY icon
4
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$484M 1.81%
1,018,633
+328,612
+48% +$151M
GOOGL icon
5
Alphabet (Google) Class A
GOOGL
$3.88T
$407M 1.52%
2,811,760
+31,000
+1% +$4.46M
META icon
6
Meta Platforms (Facebook)
META
$1.54T
$381M 1.43%
1,133,320
-28,179
-2% -$9.36M
NVDA icon
7
NVIDIA
NVDA
$5.06T
$381M 1.42%
12,949,620
+5,880
+0% +$162K
QQQ icon
8
PUT
Invesco QQQ Trust
QQQ
$460B
$370M 1.38%
930,800
+189,300
+26% +$73.1M
SPY icon
9
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$777B
$364M 1.36%
766,300
-531,500
-41% -$244M
TSLA icon
10
PUT
Tesla
TSLA
$1.2T
$317M 1.18%
898,500
+268,800
+43% +$90.2M
UNH icon
11
UnitedHealth
UNH
$385B
$227M 0.85%
452,678
+7,938
+2% +$3.59M
GOOG icon
12
Alphabet (Google) Class C
GOOG
$3.88T
$220M 0.82%
1,519,380
+51,000
+3% +$7.37M
BAC icon
13
Bank of America
BAC
$430B
$191M 0.71%
4,297,640
+35,461
+0.8% +$1.62M
AVGOP
14
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
$169M 0.63%
+81,590
New +$143M
JPM icon
15
JPMorgan Chase
JPM
$930B
$166M 0.62%
1,047,784
-179,722
-15% -$29.5M
V icon
16
Visa
V
$669B
$163M 0.61%
753,126
+3,174
+0.4% +$681K
HD icon
17
Home Depot
HD
$324B
$162M 0.61%
391,203
+47,145
+14% +$17.9M
TSLA icon
18
Tesla
TSLA
$1.2T
$148M 0.55%
420,126
+41,637
+11% +$14M
AVTR.PRA
19
DELISTED
Avantor, Inc. Series A Mandatory Convertible Preferred Stock
AVTR.PRA
$140M 0.53%
+1,086,642
New +$131M
LLY icon
20
Eli Lilly
LLY
$1.06T
$134M 0.5%
486,387
+28,041
+6% +$7.11M
CRM icon
21
Salesforce
CRM
$129B
$130M 0.48%
510,311
-16,555
-3% -$4.65M
DHR.PRA
22
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
$128M 0.48%
+58,517
New +$121M
AMAT icon
23
Applied Materials
AMAT
$447B
$122M 0.46%
775,561
-117,312
-13% -$17M
EEM icon
24
PUT
iShares MSCI Emerging Markets ETF
EEM
$28.6B
$120M 0.45%
2,462,400
+2,188,500
+799% +$110M
NKE icon
25
Nike
NKE
$60.8B
$116M 0.43%
694,747
+78,561
+13% +$13M

Similar funds

Calamos Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Calamos Advisors held 1,231 positions worth $26.7B, up 17% from $22.9B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Calamos Advisors withdrew a net $4.59B in Q4 2021, closing 114 positions and reducing 149 holdings. Its most notable exit was AstraZeneca, an estimated $17.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Calamos Advisors opened a new position in Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A worth $169M.

  • Calamos Advisors's largest Q4 2021 buy was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A: 81,590 shares worth $169M.
  • Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $151M increase.
  • Calamos Advisors's biggest Q4 2021 reduction was JPMorgan Chase, cutting an estimated $29.5M.
  • Calamos Advisors fully exited AstraZeneca in Q4 2021, selling an estimated $17.8M.
  • Calamos Advisors's ten largest holdings make up 20% of its $26.7B portfolio in Q4 2021.
  • Calamos Advisors opened 232 new positions and closed 114 in Q4 2021.
  • Calamos Advisors's portfolio value rose 17% quarter-over-quarter to $26.7B.

Based on Calamos Advisors's 13F filing for Q4 2021, filed 1 Feb 2022.